Compare FBIZ & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBIZ | SOPH |
|---|---|---|
| Founded | 1909 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.7M | 462.3M |
| IPO Year | 2012 | 2021 |
| Metric | FBIZ | SOPH |
|---|---|---|
| Price | $71.85 | $6.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $66.00 | $7.50 |
| AVG Volume (30 Days) | 62.1K | ★ 347.2K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | ★ 14.23 | N/A |
| EPS | ★ 3.28 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.69 | $23.09 |
| Revenue Next Year | $8.47 | $19.57 |
| P/E Ratio | $21.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.07 | $2.97 |
| 52 Week High | $73.48 | $6.98 |
| Indicator | FBIZ | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 76.97 | 57.62 |
| Support Level | $53.94 | $4.63 |
| Resistance Level | N/A | $6.54 |
| Average True Range (ATR) | 2.12 | 0.48 |
| MACD | 0.46 | 0.03 |
| Stochastic Oscillator | 89.24 | 48.19 |
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.